Abstract
Our study aimed to identify the correlation between the presenting FT4 values and FT4 values after the radioiodine therapy. Patients, after 10 mCi fixed dose radioiodine therapy for thyrotoxicosis were followed up at 03, 06 months intervals at Nuclear Medicine, Peradeniya. The details on base line clinical presentation, FT4 levels and the clinical status after the radioiodine therapy were collected using an interviewer administered questionnaire. Data was analysed using the SPSS version 25 by using Pearson’s correlation and independent sample t-test. There were 70.2% of Graves’ disease patients and 29.8% of toxic multi nodular goitre patients among the 57 patients consented for the follow up. The Pearson’s correlation showed a weak relationship between the FT4 value on diagnosis and the FT4 value after 03 months (r=0.475, P0.003) and a moderate relationship between the presenting FT4 value and the FT4 value before any intervention on or before 06 months after the radioiodine therapy (r=0.644, P<0.001). Before any intervention on or before 06 months from radioiodine therapy patients who were hyperthyroid had high mean FT4 value on diagnosis compared to euthyroid or hypothyroid patients (P0.009). This study has found a correlation between the FT4 value on diagnosis and the FT4 value before any intervention on or before 06 months after radioiodine therapy and the FT4 level on diagnosis can be used as a predictor for the outcome of radioiodine therapy.
Highlights
IntroductionIntroduction and BackgroundThe outcome of radioiodine therapy is influenced by factors such as age, gender, goitre size, severity of hyperthyroidism and radioiodine uptake and turnover among the hyperthyroid patients
Introduction and BackgroundThe outcome of radioiodine therapy is influenced by factors such as age, gender, goitre size, severity of hyperthyroidism and radioiodine uptake and turnover among the hyperthyroid patients
The independent sample t-test showed that the patients who were hyperthyroid 06 months after radioiodine therapy had significantly high (P=0.009) mean Free T4 (8.64ng/dl) on diagnosis compared with the patients who were euthyroid or hypothyroid 06 months after radioiodine therapy
Summary
Introduction and BackgroundThe outcome of radioiodine therapy is influenced by factors such as age, gender, goitre size, severity of hyperthyroidism and radioiodine uptake and turnover among the hyperthyroid patients. The outcome of radioiodine therapy can be influenced by factors such as age, gender, goitre size, severity of hyperthyroidism and radioiodine uptake and turnover.[18,19,20,21,22] The clinical features on diagnosis have been suggested as predictors of treatment outcome[18, 20,23]. Most of these factors are not clinically adopted and proven useful [24]. This study aimed to identify correlation between the presenting FT4 value on diagnosis and FT4 values 03, 06 months after the radioiodine therapy and to compare mean FT4 value on diagnosis between the patients who were therapeutically success and therapeutically failure from 06 months after the radioiodine therapy
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
